Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion
Research output: Contribution to journal › Article › peer-review
22Scopus
citations
Fingerprint
Dive into the research topics of 'Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion'. Together they form a unique fingerprint.